Association of the genetic polymorphisms in CYP19 with breast cancer risk in Korean women

被引:0
|
作者
Kim, J. Y. [1 ,2 ]
Jo, Y. Hwa [1 ,2 ]
Kim, H. O. [1 ,2 ]
Lee, J. [3 ]
Lee, S. S. [4 ]
Yoon, K. S. [1 ,2 ]
机构
[1] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea
[2] Kyung Hee Univ, Sch Med, Med Sci & Engn Res Ctr Bioreact React Oxygen Spec, Seoul, South Korea
[3] Kyung Hee Univ, Sch Med, Dept Pathol, Seoul, South Korea
[4] Kei Myung Univ, Sch Med, Dept Pathol, Taegu, South Korea
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:111 / 111
页数:1
相关论文
共 50 条
  • [41] Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis
    Sung Eun Hur
    Sara Lee
    Ji Young Lee
    Hye-Sung Moon
    Hyung Lae Kim
    Hye Won Chung
    Journal of Human Genetics, 2007, 52 : 703 - 711
  • [42] A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
    Talbott, Kathryn E.
    Gammon, Marilie D.
    Kibriya, Muhammad G.
    Chen, Yu
    Teitelbaum, Susan L.
    Long, Chang-Min
    Gurvich, Irina
    Santella, Regina M.
    Ahsan, Habibul
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (03) : 481 - 487
  • [43] A comprehensive haplotype analysis of CYP19 and breast cancer risk:: the Multiethnic Cohort
    Haiman, CA
    Stram, DO
    Pike, MC
    Kolonel, LN
    Burtt, NP
    Altshuler, D
    Hirschhorn, J
    Henderson, BE
    HUMAN MOLECULAR GENETICS, 2003, 12 (20) : 2679 - 2692
  • [44] A rare CYP19 (aromatase) variant may increase the risk of breast cancer
    Kristensen, VN
    Andersen, TI
    Lindblom, A
    Erikstein, B
    Magnus, P
    Borresen-Dale, AL
    PHARMACOGENETICS, 1998, 8 (01): : 43 - 48
  • [45] A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
    Kathryn E. Talbott
    Marilie D. Gammon
    Muhammad G. Kibriya
    Yu Chen
    Susan L. Teitelbaum
    Chang-Min Long
    Irina Gurvich
    Regina M. Santella
    Habibul Ahsan
    Breast Cancer Research and Treatment, 2008, 111 : 481 - 487
  • [46] Functional Genetic Polymorphisms in the CYP19 Gene Decrease the Risk of Prostate Cancer and Alter the Response to Androgen Deprivation Therapy
    Kanda, S.
    Tsuchiya, N.
    Narita, S.
    Inoue, T.
    Horikawa, Y.
    Numakura, K.
    Obara, T.
    Satoh, S.
    Habuchi, T.
    UROLOGY, 2012, 80 (03) : S100 - S101
  • [47] FUNCTIONAL GENETIC POLYMORPHISMS IN THE CYP19 GENE DECREASE THE RISK OF PROSTATE CANCER AND ALTER THE RESPONSE TO ANDROGEN DEPRIVATION THERAPY
    Kanda, Sohei
    Tsuchiya, Norihiko
    Kou, Meikoku
    Chiba, Syuji
    Satoyoshi, Kiyofumi
    Maita, Shinya
    Numakura, Kazuyuki
    Obara, Takashi
    Inoue, Takamitsu
    Narita, Shintaro
    Horikawa, Yohei
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2012, 187 (04): : E390 - E390
  • [48] THE CYP17 AND CYP19 GENE SINGLE NUCLEOTIDE POLYMORPHISM IN WOMEN WITH SPORADIC BREAST CANCER
    Sobczuk, Anna
    Romanowicz, Hanna
    Fiks, Tomasz
    Polac, Ireneusz
    Smolarz, Beata
    POLISH JOURNAL OF PATHOLOGY, 2009, 60 (04) : 163 - 167
  • [49] Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors
    Wang, Liewei
    Ellsworth, Katarzyna A.
    Moon, Irene
    Pelleymounter, Linda L.
    Eckloff, Bruce W.
    Martin, Yvette N.
    Fridley, Brooke L.
    Jenkins, Gregory D.
    Batzler, Anthony
    Suman, Vera J.
    Ravi, Saranya
    Dixon, J. Michael
    Miller, William R.
    Wieben, Eric D.
    Buzdar, Aman
    Weinshilboum, Richard M.
    Ingle, James N.
    CANCER RESEARCH, 2010, 70 (01) : 319 - 328
  • [50] Association of the polymorphisms CYP19 (TTTA)n in treatment response to hormone therapy based in aromatase inhibitors in breast cancer patients
    Murillo-Ortiz, B.
    Castillo-Valenzuela, R. dC.
    Martinez-Garza, S.
    Moreno-Perez, A.
    Silva, A.
    Ruiz-Garcia, E.
    Astudillo-de la Vega, H.
    CANCER RESEARCH, 2009, 69 (02) : 215S - 215S